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Abstract 
We report the case of a 21-year-old Nigerian
woman who presented to us with features of
intracystic papillary carcinoma, a rare form of
breast cancer usually seen in postmenopausal
women in their sixth to eighth decades of life.
To the best of our knowledge, there has been
only one other case report of this lesion occur-
ring in women in their second decade of life. 
Physical examination showed a well-defined
mass, 54 mm in diameter, in the upper proxi-
mal quadrant of the right breast close to the
areola, histologically composed of monotypic
epithelial cells disposed in solid, cystic, and
papillary  patterns.  A  diagnosis  of  intracystic
papillary carcinoma was made because of the
presence  of  intracystic  arborization  of  the
fibrovascular stroma, a monotonous cell popu-
lation, the presence of mitoses, and the lack of
myoepithelial cells determined by immunohis-
tochemistry  using  calponin  and  p63  stains.
Estrogen  receptor  status  was  positive  while
progesterone status and HER-2-neu receptor
status were negative.
The  patient  has  survived  for  12  months
without any sign of recurrence after the last
surgical resection of the tumor.
Introduction
Intracystic  papillary  carcinoma  (IPC)  is  a
variant  of  intraductal  papillary  carcinoma,  a
rare histological type of breast cancer occur-
ring only in about 1-2% of women.
1-3 Papillary
carcinomas can be divided into invasive and
noninvasive forms. Intracystic (encysted) pap-
illary carcinoma is the localized, noninvasive
form, occurring as a grossly evident tumor in a
cystic  and  dilated  duct.
2-4 The  patterns  seen
include micropapillary, cribriform, trabecular,
and solid. Occasionally they may be mistaken-
ly diagnosed as papillomas.
3,5
Because of its rarity, there is a paucity of lit-
erature on IPC in women younger than thirty
years old, as it predominantly affects elderly,
postmenopausal  women.
1 It  has  been  docu-
mented in males as well.
1,6 To the best of our
knowledge, there has been only one other case
report  of  this  lesion  occurring  in  pre-
menopausal women in their second decade of
life.
4 We recently encountered a case of low
nuclear grade intracystic papillary carcinoma
of  the  right  breast  in  a  21-year-old  woman,
which is probably the first report in our envi-
ronment.
Case Report
Clinical history
A 21-year-old woman presented in our surgi-
cal  out-patient  department  with  a  four-year
history of a right breast mass and bloody nip-
ple discharge. Her family history was negative
for breast cancer and there was no history of
exposure to anticancer drugs, radiation, or cig-
arette  smoking.  Clinical  examination  con-
firmed  a  well-defined  54-mm  mass  in  the
upper proximal quadrant of the right breast
close to the areola, with an ipsilateral bloody
nipple  discharge  (Figure  1).  There  was  no
associated axillary lymphadenopathy. 
Mammography was not performed as facili-
ties for this are unavailable in the state. Core
needle biopsy was performed using a 23-gauge
needle and showed a papillary tumor histolog-
ically composed of monotypic epithelial cells.
The preliminary diagnosis was atypical ductal
papilloma  with  a  differential  diagnosis  of
intracystic  papillary  carcinoma.  Four  weeks
after the core biopsy, excision biopsy of the
tumor was performed. 
Pathological features
Grossly the excised tissue showed a mass of
fibro-fatty tissue weighing 101 g and measur-
ing 80x60x12 mm. The cut surface of the tis-
sue showed a well-defined mass approximate-
ly 17 mm in diameter, with a cystic cavity filled
with pale, friable, papillary tissue. Histologic  -
ally the tumor was composed of closely packed
epithelial cells (nuclear Grade 2) with a papil-
lary  architecture  within  a  cyst  (Figure  2).
Biopsy site changes were apparent in the sur-
rounding tissue. 
Immunohistochemical  (IHC)  stains  for
calponin, p63, and CK5/6 were performed on
the tumor and demonstrated the absence of a
myoepithelial cell border in the papillary cores
as well as at the periphery of the lesion. Based
on these findings, the diagnosis of intracystic
papillary  carcinoma  was  made.  Hormone
receptor analysis showed mild estrogen recep-
tor  positivity  (1+)  while  both  progesterone
and HER-2-neu were negative. 
The patient had another excision 15 weeks
later  because  of  involved  margins,  which
revealed residual papillary lesions as well as a
few  foci  of  mucinous  carcinoma.  Based  on
this associated pathology and her age, we con-
sidered adjuvant radiotherapy appropriate for
her but opted for tamoxifen when her family
expressed  their  inability  to  cope  with  the
inconvenience and expense of radiotherapy in
another center. Although she is yet to comply
with hormonal therapy for poorly understood
reasons, she has been symptom-free for about
a year.
Discussion
Typically patients with IPC present with a
palpable  mass  (80%  or  more)  and/or  bloody
nipple discharge (up to 22%).
6,7 Less frequent-
ly they may present as a radiographic abnor-
mality.
8 Most  patients  are  postmenopausal
women usually with median ages ranging from
63-75 years.
6,7,9 Its occurrence in this 21-year-
old was a novelty. The duration of symptoms in
patients with IPC varies but prolonged periods
of one year or more is not considered unusual.
1
Late presentation, as seen in our patient who
had a four-year history, is a typical feature of
most  patients  with  breast  cancer  in  sub-
Saharan Africa, in contrast to what occurs in
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the  developed  world  where  patients  present
with a median duration of symptoms of  six
weeks before diagnosis.
7,10
Mammography, ductography, galactography,
ultrasonography,  and  magnetic  resonance
imaging (MRI) are imaging techniques useful
in the diagnosis of breast cancer.
8,11,12 On mam-
mography IPC often is seen as a round or oval
circumscribed  mass,  frequently  in  the
retroareolar  region.  Spiculation  is  rare.
Ductography and galactography may be com-
bined with mammography in patients with nip-
ple  discharge  to  show  filling  defects,  ductal
obstructions,  and  ductal  wall  irregularities,
while  sonography  usually  reveals  intracystic
mural  nodules,  papillary  projections,  and
septa.
8,11-13 In  resource-poor  countries  like
Nigeria,  where  mammographic  facilities  are
expensive  and  largely  unavailable,  interven-
tional  procedures  like  core  needle  biopsies
often are performed blind, and surgeons have
to depend on pathological evaluation of tumor
resection margins solely, as a means to ensure
postoperative  removal  of  all  of  the  tumor.
Accurate diagnosis in patients with multicen-
tric  tumors  is  limited.  Universally,  young
patients like ours usually are not subjected to
screening  mammography  because  of  their
increased breast density, except in high risk
women  or  those  with  a  prior  diagnosis  of
breast cancer.
12
Microscopically  IPC  is  composed  of  an
encysted  tumor  within  a  dilated  duct  with
arborization of the fibrovascular stroma, and
contains nodules of papillary carcinoma sur-
rounded  by  a  thick  fibrous  capsule.
1-2,6-7
Excision biopsy is recommended for pathologi-
cal diagnosis because of the frequently incon-
clusive  findings  associated  with  fine  needle
aspiration  or  core  needle  biopsy  alone.
2
Immunohistochemistry  with  stains  such  as
calponin, smooth-muscle myosin heavy chain
(SMM-HC)  cytoplasmic  stains,  and  p63
nuclear stains have been invaluable in distin-
guishing IPC, which does not appear to have a
myoepithelial cell layer around tumor nodules,
from  ductal  carcinoma  in  situ (DCIS).
2,14-15
Another differential diagnosis, papilloma, can
be distinguished from IPC using the criteria
proposed by Kraus and Neubecker.
5Usually IPC
presents with low to intermediate grade, high
estrogen and progesterone receptor positivity,
and negativity for c-erb-2.
3,7
There are no well-defined views on the man-
agement of IPC; however, surgical excision is
the mainstay of treatment.
6-7,16 In selected stud-
ies, patients with IPC were divided into three
groups (IPC alone, IPC with associated ductal
carcinoma  in  situ,  and  IPC  with  associated
invasion with or without ductal carcinoma in
situ), and the prognosis did not differ among
the three groups regardless of the type of sur-
gery performed (breast-conserving surgery or
mastectomy)  and  whether  adjuvant  therapy
was administered.
7,16-18 Fayanju et al.
18 observed
that patients with IPC and associated DCIS or
microinvasion were treated with adjuvant radi-
ation and endocrine therapy on the basis of
this associated pathology. Therefore sentinel
lymph  node  biopsy  has  been  advocated  for
these patients
6,7,14 owing to the low rate of axil-
lary lymph node metastases (8-11%) observed
in  those  evaluated  for  regional  disease.
9,19
Sentinel lymph node biopsy also seems justi-
fied in large IPC tumors owing to the occasion-
al axillary lymph node involvement observed in
a  few  cases  of  pure  IPC
7,20 characterized  by
lesions measuring 4 cm or more. Pure IPC has
been reported to have an excellent prognosis
even when treated with local excision only, but
the current clinical management remains vari-
able  with  a  potential  for  overtreatment.
7,16,17
Only  in  a  subset  of  younger  patients  (<50
years old) with pure IPC was adjuvant radio-
therapy and/or hormonal therapy administered
and this is recommended.
18
The prognosis of IPC, particularly in elderly
women,  is  excellent  with  few  or  no  cancer-
related deaths in most study series.
6,7 In con-
trast  to  the  lower  relative  survival  rate  for
patients with non-IPC cancers such as invasive
ductal carcinoma, even patients with invasive
IPC had a survival rate of >90% of that of the
general  population.
6 Factors  such  as  age  at
presentation,  tumor  diameter,  and  nuclear
grade, necrosis, and the presence of associat-
ed lesions such as invasion and DCIS, all affect
patient survival.
2,9,16-19
In summary, intracystic papillary carcinoma
is extremely rare in women in their second
decade of life but it does occur. The diagnosis
depends  on  finding  typical  clinical  features,
radiologic and pathologic investigations and,
invariably, immunohistochemistry. The tumor
should be managed with or without adjuvant
therapy on the basis of any associated patholo-
gy, tumor size, and age of the patient. Although
our  patient  has  been  symptom-free  for  one
year now, the prognosis in this age group is yet
to be evaluated.
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